IonQ IONQ 深 滬
等待開盤 12-18 09:30:00 美东时间
45.85
-3.820
-7.69%
華盛通- 最 高52.1505
- 今 開50.22
- 成交量 2023.65万股
- 最 低 45.76
- 昨 收 49.67
- 總市值 120.13亿
- 52周最高 84.64
- 市盈率 靜 --
- 換手率 7.72%
- 52周最低 17.88
- 委 比 -85.92%
- 總股本 2.62亿
- 歷史最高 84.64
- 量 比 1.16
- 振 幅 12.87%
- 歷史最低 3.04
- 每 手 1
- 風險率 13.45%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
今天 10:54
IonQ and QuantumBasel expand long-term partnership
IonQ (IONQ) announced on Wednesday an expanded agreement with QuantumBasel, the quantum initiative of uptownBasel, Switzerland’s innovation campus. The extended contract grants QuantumBasel ownership...
今天 05:28
IonQ Expands Agreement With QuantumBasel, Secures Ownership Of Next-Gen Tempo System
Extension solidifies QuantumBasel as IonQ's Innovation Center in Europe; adds IonQ Tempo and next-generation system to advance quantum commercializationIonQ (NYSE:IONQ), the world's leading quantum company, today
今天 05:12
What's Going On With Quantum Computing Stocks Today?
Shares of quantum computing stocks rose on Wednesday after Wedbush initiated coverage on the sector.
今天 00:24
Wedbush Initiates Coverage On IonQ with Outperform Rating, Announces Price Target of $60
Wedbush analyst Antoine Legault initiates coverage on IonQ (NYSE:IONQ) with a Outperform rating and announces Price Target of $60.
12-17 21:38
Jefferies Sees $198 Billion Revenue Potential By 2040 For Quantum Computing
The quantum computing industry is currently generating $1 billion in revenue, but this figure could skyrocket to $198 billion by 2040, according to a recent report by Jefferies analysts.
12-17 21:31
Wedbush initiates coverage on quantum computing stocks
Wedbush Securities initiated coverage on quantum computing stocks on Wednesday, putting Outperform ratings on IonQ (IONQ), Rigetti (RGTI) and D-Wave Quantum (QBTS) and a Neutral rating on Quantum Comp...
12-17 20:43
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
12-17 10:46
IONQ, QBTS: Jefferies Sounds the Bullhorn on These 2 Quantum Stocks
Jefferies is turning more optimistic on quantum computing. Top analyst Kevin Ga...
12-17 07:40
